|
This 90-minute webinar will help you identify the challenges in Phase I and FIM studies and present solutions on how to overcome these challenges. As need for more aggressive drug development that still ensures the safety of the subjects and the drug itself becomes more and more important, the challenges of those individuals responsible for the Phase I activities increase exponentially. To not meet these challenges has consequences. Areas Covered in the Seminar: - What are the factors in choosing a defendable first dose of a NCE
- How to Set up of a site that is prepared for First-in-man studies
- How to develop an effective / efficient Phase I Program to be audit clear
- How to recruit Study Participants in this new age of Social Media
- How to not miss and accurately assess important Adverse Events
- How a well written Protocol prevents errors and warning letters
- How to not miss “safety Assessments” when you really do not know what to look for
For Registration:http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702242?channel=Eventsbot
|